Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - GENOPTIX INC | dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 25, 2010
GENOPTIX, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 001-33753 | 33-0840570 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
1811 Aston Avenue
Carlsbad, CA 92008
(Address of principal executive offices, including zip code)
(760) 268-6200
Registrant’s telephone number, including area code
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02. | Results of Operations and Financial Condition. |
On February 25, 2010, Genoptix, Inc., a Delaware corporation, issued a press release announcing, among other things, its financial results as of and for the fourth quarter and fiscal year ended December 31, 2009. A copy of the press release is attached as Exhibit 99.1 to this current report.
The information in this Item 2.02 and Exhibit 99.1, attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission, whether filed before or after the date hereof, and regardless of any general incorporation language in any such filing.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
| 99.1 | Press Release of Genoptix, Inc. dated February 25, 2010. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| GENOPTIX, INC. | ||
| Date: February 25, 2010 | /s/ CHRISTIAN V. KUHLEN | |
| Christian V. Kuhlen, M.D., Esq. | ||
| Vice President, General Counsel | ||
EXHIBIT INDEX
| Exhibit |
Description | |
| 99.1 | Press Release of Genoptix, Inc. dated February 25, 2010. | |